286-300 of 931
AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
Project Oncology®AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Project Oncology®Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
Project Oncology®Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
Alexis Leonard
CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Project Oncology®CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Alexis Leonard
Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
Project Oncology®Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
David Jacobsohn
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Project Oncology®Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Alexis Leonard
- advertisement
Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Project Oncology®Crizanlizumab’s Role in Reducing Vaso-Occlusive Crises and Opioid Use in SCD
Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Project Oncology®Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Project Oncology®Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
Charles Turck, PharmD, BCPS, BCCCP
Jonathon B. Cohen, MD, MS
Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
GI InsightsDiagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
Peter Buch, MD, FACG, AGAF, FACP
Yinghong Wang, MD, PhD, MS
Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Project Oncology®Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
Ashley Baker, MSN, PMHNP
Alyssa Schlenz
Shannon Phillps
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Hallie Blevins, PhD
- advertisement
Optimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Deep Breaths: Updates from CHESTOptimizing Treatment Pathways in NSCLC: The Role of the Multidisciplinary Team
Gerard A. Silvestri MD, MS
Jessica S. Donington, MD, MSCR
Mariam Alexander, MD, PhD
Anurag Singh, MD
Evolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Deep Breaths: Updates from CHESTEvolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
Gerard A. Silvestri MD, MS
Jessica S. Donington, MD, MSCR
Mariam Alexander, MD, PhD
Anurag Singh, MD
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Ryan Quigley